Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy

This publication has 15 references indexed in Scilit:

• Cancer statistics, 1999
  CA: A Cancer Journal for Clinicians, 1999
• THE VALUE OF A REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION ASSAY IN PREOPERATIVE STAGING AND FOLLOWUP OF PATIENTS WITH PROSTATE CANCER
  Journal of Urology, 1998
• Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) Messages
  Urology, 1997
• Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma
  Urology, 1997
• PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
  Urologic Clinics of North America, 1997
• Preoperative Reverse Transcriptase Polymerase Chain Reaction for Prostate Specific Antigen Predicts Treatment Failure Following Radical Prostatectomy
  Journal of Urology, 1996
• Prediction of Progression Following Radical Prostatectomy
  The American Journal of Surgical Pathology, 1996
• Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
  Urology, 1994
• The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer
  Journal of Urology, 1993
• Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels
  Cancer, 1993